February 2012 Drug Update Information - Pharmacy Benefits ...
February 2012 Drug Update Information - Pharmacy Benefits ...
February 2012 Drug Update Information - Pharmacy Benefits ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=882<br />
Source: http://www.a<br />
ashp.org<br />
Nitazoxanide Tablets<br />
January 31, <strong>2012</strong><br />
Products Affected - Description<br />
Alinia, Romark Laboratories<br />
500 mg tablets, 30 count bottles (NDC 67546-0111-12)<br />
500 mg tablets, 60 count bottles (NDC 67546-0111-11)<br />
100 mg/5<br />
mL powder for suspension, 60 mL<br />
bottle (NDC<br />
67546-0212-21)<br />
Reason for the Shortage<br />
Romark states the reason for the shortage is manufacturin<br />
ng delay.<br />
Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=879<br />
Source: http://www.a<br />
ashp.org<br />
Metoclopramide Injection<br />
January 31, <strong>2012</strong><br />
Products Affected - Description<br />
Metoclopramide injection, Hospira<br />
5 mg/mL, 2 mL vials<br />
(NDC 00409-341401)<br />
Reason for the Shortage<br />
Baxter had metoclopramide injection on back<br />
order due to regulatory<br />
issues. Baxter sold some<br />
generic injectable products to West-Ward. West-Ward then discontinued the metoclopramide<br />
injection in January, <strong>2012</strong>.<br />
Teva discontinued metocloprami<br />
ide injectionn in <strong>February</strong>, 2011.<br />
Hospira discontinued<br />
d metoclopramide ampules in <strong>February</strong>, 2010, and Carpuject<br />
syringes in<br />
May, 2009. Hospira is the only manufacturer<br />
r of metoclopramide injection.<br />
Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=611<br />
Source: http://www.a<br />
ashp.org<br />
Glycopyrrolate Injection<br />
January 31, <strong>2012</strong><br />
Products Affected - Description<br />
Glycopyrrolate 0.2 mg/mL injection, West-Ward<br />
1 mL vial (NDC 10019-0016-81)<br />
2 mL vial (NDC 10019-0016-17)<br />
5 mL vial (NDC 10019-0016-54)<br />
20 mL vial (NDC 10019-0016-02)<br />
Robinul 0.2 mg/mL injection, West-Ward<br />
1 mL vial (NDC 60977-0155-01)<br />
2 mL vial (NDC 60977-0155-02)<br />
5 mL vial (NDC 60977-0155-03)<br />
20 mL vial (NDC 60977-0155-06)<br />
Reason for the Shortage<br />
West-Ward has acquired all Baxter Robinul and generic glycopyrrolate injectionn products. West-<br />
Ward cannot provide<br />
a reason for the shortage.<br />
American<br />
Regent had<br />
temporarily suspendedd manufacture of most drug products<br />
in April, 2011.<br />
American<br />
Regent resumed manufacturing in Shirley, New<br />
York in early-May, 2011.<br />
Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=385<br />
Source: http://www.a<br />
ashp.org<br />
43